AI lab aims to "Solve all diseases" with human drug trials
Isomorphic Labs, a company born from Google DeepMind and now part of Alphabet, is about to start testing the first-ever drugs created entirely by artificial intelligence on real people.
Their main goal? To speed up drug development—which usually takes years—and make treatments more effective, especially for cancer.
How the AI helps in drug discovery
They're using AlphaFold 3, an award-winning AI that can predict how proteins and molecules interact inside our bodies.
This lets scientists design new medicines digitally before ever mixing chemicals in a lab.
With $600 million in funding and partnerships with big names like Novartis and Eli Lilly, Isomorphic Labs is betting big on this tech.
Questions that need to be answered
While faster drug discovery sounds awesome, there are some tough questions: Who owns AI-made medicines? Will everyone be able to afford them? And if something goes wrong, who's responsible?
As these high-tech drugs move closer to reality, making sure they're safe and accessible will be just as important as the science itself.